Recruiting NA Overweight or Obesity

New treatment option for Overweight or Obesity

Official title NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks

ClinicalTrials.gov ID: NCT05674799

What this study is testing

What it's testing
The goal of this clinical trial is to test an enhanced version of the National Diabetes Prevention Program (NDPP-NextGen) that is tailored to young women in childbearing years. The investigators will recruit 360 women aged 18-39 years with overweight/obesity who are not currently pregnant, but likely to conceive within 24 months.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 39, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Established patient at Denver Health or Atrium Health Wake Forest Baptist
  • Biologically female (inclusive of all gender identities)
  • Aged 18-39 years
  • English- or Spanish-speaking
  • BMI ≥25 kg/m2 (≥23 kg/m2 if Asian race)

You likely can't join if

  • Currently pregnant
  • Non-gestational diabetes (type 1, type 2)
  • Long-acting contraceptives (intrauterine device, implant, injection) with plans to continue for \>1 year (barrier \& short-acting hormonal...
  • Medical procedures (e.g., tubal ligation, hysterectomy) or conditions that impede pregnancy
  • Documented infertility or unsuccessfully trying to conceive for ≥12 months
  • Prior participation in the NDPP
See the full eligibility criteria
Who can join
  • Established patient at Denver Health or Atrium Health Wake Forest Baptist
  • Biologically female (inclusive of all gender identities)
  • Aged 18-39 years
  • English- or Spanish-speaking
  • BMI ≥25 kg/m2 (≥23 kg/m2 if Asian race)
  • Activities that lead to pregnancy in past 3 months
  • Interested in pregnancy within 24 months, including:
  • High interest (actively trying to conceive)
  • General interest (not actively trying but wanting to become pregnant in the foreseeable future)
  • Neutral interest (not planning pregnancy or using contraception for religious reasons)
What rules you out
  • Currently pregnant
  • Non-gestational diabetes (type 1, type 2)
  • Long-acting contraceptives (intrauterine device, implant, injection) with plans to continue for \>1 year (barrier \& short-acting hormonal contraception permitted given ease of discontinuing to facilitate pregnancy)
  • Medical procedures (e.g., tubal ligation, hysterectomy) or conditions that impede pregnancy
  • Documented infertility or unsuccessfully trying to conceive for ≥12 months
  • Prior participation in the NDPP
  • History of bariatric surgery
  • Use of GLP-1s in last year
  • Currently receiving clinical obesity treatment

The study team makes the final eligibility decision.

Where it's taking place

  • Winston-Salem, North Carolina, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 39 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Winston-Salem, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.